Putting Proteomics Into Immunotherapy for Glioblastoma

In glioblastoma, the most aggressive brain cancer, a complex microenvironment of heterogeneity and immunosuppression, are considerable hurdles to classify the subtypes and promote treatment progression. Treatments for glioblastoma are similar to standard therapies for many other cancers and do not e...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Liangyu, Qin, Di, Guo, Xinyu, Wang, Qixue, Li, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940695/
https://www.ncbi.nlm.nih.gov/pubmed/33708196
http://dx.doi.org/10.3389/fimmu.2021.593255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940695/
https://www.ncbi.nlm.nih.gov/pubmed/33708196
http://dx.doi.org/10.3389/fimmu.2021.593255

Ejemplares similares